Archives: Contractor Email

Dear Contractor

SPPG have issued CPVS Update 14 on 22nd March 2024 relating to the Autumn COVID-19 and Seasonal Flu Vaccination Service.

SUMMARY

  • The Autumn COVID-19 and Seasonal Flu CPVS programmes will finish on 31st March 2024 and providers are asked not to vaccinate eligible patients for the Autumn 23/24 after this date.
  • Pharmacies should not order any further Comirnaty (Pfizer) XBB COVID-19 vaccines and any residual stock after the 31st March 2024 may be disposed of in waste bins.
  • The CMO letter issued 8th March gives some details of the Spring booster programme and further information will be issued by SPPG shortly.

ACTION

  • Contractors should review the CPVS update and share this information with relevant members of the pharmacy team. 
  • Any residual Comirnaty (Pfizer) XBB COVID-19 vaccine stock after 31st March 2024 should be disposed of in waste bins as these vaccines will not be used for the Spring 2024 COVID-19 vaccination programme.

Any queries regarding the Community Pharmacy Vaccination Service should be directed to Greg Miller  (Greg.Miller@hscni.net) or Grainne McMahon (Grainne.McMahon4@hscni.net).

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for March 2024:
DrugPack SizeConcessionary Price
Anastrozole 1mg tablets28£1.45
Azithromycin 250mg capsules6£4.45
Baclofen 10mg tablets84£4.22
Clarithromycin 125mg/5ml oral suspension70£4.14
Clarithromycin 250mg/5ml oral suspension70£5.86
Clotrimazole 500mg pessaries1£9.45
Co-amoxiclav 250mg/125mg tablets21£3.78
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free100£2.20
Cyclizine 50mg tablets100£3.95
Dorzolamide 20mg/ml eye drops5£3.41
Duloxetine 60mg gastro-resistant capsules28£3.49
Esomeprazole 40mg gastro-resistant capsules28£3.82
Etoricoxib 60mg tablets28£15.14
Etoricoxib 90mg tablets28£14.33
Fenofibrate micronised 160mg tablets28£3.40
Haloperidol 5mg tablets28£3.84
Mebeverine 200mg modified-release capsules60£6.70
Methylphenidate 10mg tablets30£2.98
Mometasone 0.1% ointment30£3.55
Mycophenolate mofetil 500mg tablets50£7.97
Nebivolol 2.5mg tablets28£11.51
Nebivolol 5mg tablets28£6.00
Nortriptyline 10mg tablets100£2.22
Olanzapine 10mg tablets28£1.30
Pregabalin 200mg capsules84£3.81
Quetiapine 100mg tablets60£2.33
Quinine sulfate 300mg tablets28£3.65
Ropinirole 2mg tablets28£31.51
Sodium valproate 200mg/5ml oral solution sugar free300£7.78
Zopiclone 3.75mg tablets28£1.70
Zopiclone 7.5mg tablets28£1.56

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

SPPG have issued correspondence 19th March 2024 regarding the Living Well Service.

SUMMARY

  • The first campaign of 24/25 ‘Cancer Screening Saves Lives’ will commence 1st April 2024. The campaign aims to increase awareness of the cancer screening programmes available in NI.
  • Resources will be provided by 28th March 2024 and as per service specification, posters should be displayed in at least one window of the pharmacy.
  • NICPLD are hosting a webinar that is available to community pharmacists on 9th April 2024 at 7pm. Visit NICPLD website for more details.
  • PHA will be releasing social media posts in relation to this campaign and these can be shared on your channels. Details of the schedule is available on BSO website.

ACTION

  • Contractors are asked to read the correspondence issued by SPPG 19th March 2024 regarding the Living Well Service and share with all relevant members of the team.
  • If the resources for the first campaign ‘Cancer Screening Saves Lives’ are not received by 28th March 2024 email reception.pha@hscni.net immediately and ensure email subject is titled ‘LIVING WELL PHARMACY CAMPAIGN’. Failure to report this by 8th April 2024 will result in no resources being provided.
  • The current campaign ‘Know Your Units’ will finish on 31st March 2024 and the survey will run from 1st April until 6pm 29th April.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The first update of concessionary prices were granted today for March 2024:
DrugPack SizeConcessionary Price
Amiodarone 200mg tablets28£1.83
Aripiprazole 10mg tablets28£7.89
Aripiprazole 15mg tablets28£8.47
Baclofen 5mg/5ml oral solution sugar free300£3.64
Betamethasone valerate 0.1% cream30£1.43
Betamethasone valerate 0.1% cream100£4.99
Bimatoprost 100micrograms/ml eye drops3£4.46
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops3£8.79
Bumetanide 1mg tablets28£2.35
Cefalexin 250mg capsules28£2.06
Co-careldopa 12.5mg/50mg tablets90£4.25
Co-codamol 15mg/500mg tablets100£3.25
Dexamfetamine 5mg tablets28£22.83
Digoxin 125microgram tablets28£2.75
Digoxin 250microgram tablets28£2.75
Digoxin 62.5microgram tablets28£2.75
Docusate 50mg/5ml oral solution sugar free300£17.79
Donepezil 5mg tablets28£1.50
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free60£25.03
Duloxetine 20mg gastro-resistant capsules28£8.88
Duloxetine 40mg gastro-resistant capsules56£11.25
Escitalopram 10mg tablets28£1.27
Estradiol 10microgram pessaries24£10.75
Ezetimibe 10mg tablets28£12.86
Haloperidol 1.5mg tablets28£3.66
Hydrocortisone 2.5% cream15£47.25
Irbesartan 300mg tablets28£1.35
Isotretinoin 20mg capsules30£10.78
Lamotrigine 100mg tablets56£3.20
Lamotrigine 200mg tablets56£4.81
Lamotrigine 25mg tablets56£1.92
Lamotrigine 50mg tablets56£2.84
Lansoprazole 30mg gastro-resistant capsules28£1.30
Memantine 10mg tablets28£1.30
Memantine 10mg/ml oral solution sugar free50£45.45
Memantine 20mg tablets28£1.58
Metformin 1g modified-release tablets56£2.71
Metformin 500mg modified-release tablets56£1.83
Metoprolol 50mg tablets28£3.75
Midazolam 10mg/2ml solution for injection ampoules10£5.39
Mometasone 50micrograms/dose nasal spray140£9.20
Montelukast 10mg tablets28£2.05
Montelukast 5mg chewable tablets sugar free28£1.21
Morphine sulfate 10mg/5ml oral solution300£5.45
Orlistat 120mg capsules84£23.35
Pregabalin 150mg capsules56£2.25
Primidone 250mg tablets100£86.95
Risperidone 1mg/ml oral solution sugar free100£3.13
Risperidone 2mg tablets60£1.99
Ropinirole 500microgram tablets28£15.75
Simvastatin 20mg tablets28£1.10
Simvastatin 80mg tablets28£1.61
Terbinafine 1% cream15£3.51
Terbinafine 1% cream30£7.02
Trazodone 150mg tablets28£2.14
Trospium chloride 20mg tablets60£11.36
Zolmitriptan 2.5mg tablets6£16.45
Zolmitriptan 2.5mg tablets12£32.90
Zonisamide 50mg capsules56£16.73

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague

Correspondence has been issued by SPPG 14th March 2024 regarding the Community Pharmacy Assurance Framework.

SUMMARY

  • SPPG is seeking completion of the Community Pharmacy Assurance Framework (CPAF) declaration form for your pharmacy, for the 2023/24 year.
  • The aim and purpose of the framework is to monitor compliance with Terms of Service, service specifications, related professional standards and best practice guidance.
  • SPPG has recently worked with CPNI to review, update and agree the Assurance framework for the 2023/24 year.
  • A payment of £1200 will be made to each pharmacy, upon return of the completed declaration, for compliance with the CPAF process in 2023/24.
  • The recently resumed CPAF visits will continue, and pharmacies will be contacted directly if selected for a visit.

ACTION

  • Contractors are asked to review the correspondence and share with all relevant team members.
  • The declaration form must be completed no later than Wednesday 27th March 2024, and can be accessed by the following link.
  • A copy of the current practice leaflet and the complaints procedure/SOP should be submitted via email to your local office by 31st March 2024.
  • CPNI have produced a guidance document and resources to support you with CPAF, available on CPNI’s website HERE.
  • Please contact the Pharmacy Advisor at your local office for any queries.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive